- Home
- ALLR vs SINT Comparison
ALLR vs SINT Comparison
Compare ALLR & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- SINT
- Stock Information
- Founded
- ALLR 2004
- SINT 1996
- Country
- ALLR United States
- SINT United States
- Employees
- ALLR N/A
- SINT N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- SINT Medical/Dental Instruments
- Sector
- ALLR Health Care
- SINT Health Care
- Exchange
- ALLR Nasdaq
- SINT Nasdaq
- Market Cap
- ALLR 2.3M
- SINT 2.2M
- IPO Year
- ALLR N/A
- SINT 2014
- Fundamental
- Price
- ALLR $1.32
- SINT $2.04
- Analyst Decision
- ALLR
- SINT Hold
- Analyst Count
- ALLR 0
- SINT 1
- Target Price
- ALLR N/A
- SINT N/A
- AVG Volume (30 Days)
- ALLR 658.4K
- SINT 48.8K
- Earning Date
- ALLR 11-14-2024
- SINT 11-12-2024
- Dividend Yield
- ALLR N/A
- SINT N/A
- EPS Growth
- ALLR N/A
- SINT N/A
- EPS
- ALLR N/A
- SINT N/A
- Revenue
- ALLR N/A
- SINT $3,247,000.00
- Revenue This Year
- ALLR N/A
- SINT $10.77
- Revenue Next Year
- ALLR N/A
- SINT $19.38
- P/E Ratio
- ALLR N/A
- SINT N/A
- Revenue Growth
- ALLR N/A
- SINT 30.40
- 52 Week Low
- ALLR $1.26
- SINT $2.01
- 52 Week High
- ALLR $666.00
- SINT $105.80
- Technical
- Relative Strength Index (RSI)
- ALLR 32.39
- SINT 24.04
- Support Level
- ALLR $1.32
- SINT $2.77
- Resistance Level
- ALLR $1.53
- SINT $3.12
- Average True Range (ATR)
- ALLR 0.12
- SINT 0.22
- MACD
- ALLR 0.05
- SINT -0.09
- Stochastic Oscillator
- ALLR 14.63
- SINT 2.31
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is an advanced ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing primarily on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming an advanced ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have superb bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.